ClinicalTrials.gg
Drug

Icotinib clinical trials

Also written BPI-2009.

Includes 6 studies of Icotinib hydrochloride.

studies test it
76
open now
8
in phase 3
11
first study started
2009

How each study uses icotinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the icotinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Icotinib
59
Conmana
25
Commana
11
Comana
3
BPI-2009, Conmana
2

Development codes

BPI-2009
20
BPI-9000
1

Studies by the year they started

76 studies that test it; most in 2014 (15)

Studies that test icotinib, by start year
YearStudies
20091
20101
20113
201210
20137
201415
201510
201610
20173
20186
20192
20212
20223
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
8
Phase 2
48
Phase 3
11
Phase 4
9
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 36 · Other 40

Betta Pharmaceuticals Co., Ltd. (36) · Sun Yat-sen University (5) · Tianjin Medical University Cancer Institute and Hospital (4) · Nanfang Hospital, Southern Medical University (3) · Zhejiang Cancer Hospital (2) · Chinese Academy of Medical Sciences (2) · Zhejiang University (2) · Yuhong Li (1)

Often tested with

Tested in the same studies.

Befotertinib (2) · Bevacizumab (1) · Anlotinib (1) · Antineoplastic Agents (1) · Gefitinib (1) · Rezivertinib (1) · Benmelstobart (1) · Pemetrexed (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses icotinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 76

See all 76 studies that test icotinib →

Given beside what is tested · 4 — icotinib is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with icotinib

Codes

What other systems call icotinib · ClinicalTrials.gg INT005324

  • MeSH (NLM) C531470icotinibOne source NLM
  • UNII (FDA) 9G6U5L461QICOTINIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q16868421icotinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C138996IcotinibOne source FDA
  • DrugBank DB11737One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.